找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Gastrointestinal Cancer; A Comprehensive Guid Hoon Jai Chun,Seun Ja Park,Si Young Song Book 2023 The Editor(s) (if applicable) and The Auth

[復(fù)制鏈接]
樓主: 能干
21#
發(fā)表于 2025-3-25 06:29:20 | 只看該作者
Prithvi Raj,Hans Nolte,Michael Stanton-Hicksclinical outcomes of radiation therapy alone are unsatisfactory and are not recommended as an option for first-line treatment. When radiotherapy and chemotherapy are combined, the local cure rate and survival rate improve greatly, and several clinical studies have been published showing clinical out
22#
發(fā)表于 2025-3-25 10:56:24 | 只看該作者
https://doi.org/10.1007/978-3-642-49157-3ncer have been gradually declining in recent decades, the most recent epidemiological study reports that gastric cancer is the fifth most common cancer, accounting for 5.6% of all cancers worldwide, while gastric cancer-related mortality is the fourth most common, accounting for 7.7% of all cancer-related mortality [1].
23#
發(fā)表于 2025-3-25 14:56:09 | 只看該作者
Ludwig Heilmeyer,Herbert Begemannchemotherapy and supportive care can be used for stage IV patients with distant metastases, as recommended by the Korean [1] and Japanese [2] guidelines established in 2018. Table 1 shows the stages, and Table 2 summarizes the treatment plans according to the clinical and pathological stages. Figures 1 and 2 illustrate the treatment algorithm.
24#
發(fā)表于 2025-3-25 16:34:47 | 只看該作者
Wolf-Dieter Heiss,Curt Beil,Klaus Wienhard, nodal involvement, and presence of metastases that make up the TNM staging classification. Optimal staging and optimal treatment decisions based on stage, histologic type, and location of the disease are very important.
25#
發(fā)表于 2025-3-25 22:45:07 | 只看該作者
26#
發(fā)表于 2025-3-26 04:05:49 | 只看該作者
27#
發(fā)表于 2025-3-26 06:32:37 | 只看該作者
28#
發(fā)表于 2025-3-26 11:23:10 | 只看該作者
,MR-Angiographie der supraaortalen Gef??e, the last treatment option. Compared to the best supportive care, palliative chemotherapy can significantly improve patient’s quality of life and survival [1]. This chapter will review the chemotherapy regimens currently available in these clinical settings.
29#
發(fā)表于 2025-3-26 16:39:45 | 只看該作者
30#
發(fā)表于 2025-3-26 19:24:23 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 12:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
句容市| 东阳市| 阿克陶县| 阿拉尔市| 朝阳区| 普格县| 余姚市| 岐山县| 宁德市| 饶阳县| 巨鹿县| 左云县| 芒康县| 龙海市| 台南县| 江山市| 麦盖提县| 泗阳县| 镇安县| 五常市| 遂宁市| 万年县| 刚察县| 顺昌县| 南雄市| 清水河县| 大竹县| 彭阳县| 全南县| 偏关县| 紫金县| 广元市| 荣昌县| 永宁县| 灌云县| 万载县| 阳江市| 台山市| 连州市| 渑池县| 山东省|